The interplay between autophagy and ROS in tumorigenesis
Open Access
- 1 January 2012
- journal article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 2, 171
- https://doi.org/10.3389/fonc.2012.00171
Abstract
Reactive oxygen species (ROS) at physiological levels are important cell signaling molecules. However, aberrantly high ROS are intimately associated with disease and commonly observed in cancer. Mitochondria are primary sources of intracellular ROS, and their maintenance is essential to cellular health. Autophagy, an evolutionarily conserved process whereby cytoplasmic components are delivered to lysosomes for degradation, is responsible for mitochondrial turnover and removal of damaged mitochondria. Impaired autophagy is implicated in many pathological conditions, including neurological disorders, inflammatory bowel disease, diabetes, aging and cancer. The first reports connecting autophagy to cancer showed that allelic loss of the essential autophagy gene BECLIN1 (BECN1) is prevalent in human breast, ovarian and prostate cancers and that Becn1+/- mice develop mammary gland hyperplasias, lymphomas, and lung and liver tumors. Subsequent studies demonstrated that Atg5-/- and Atg7-/- livers give rise to adenomas, Atg4-/- mice are susceptible to chemical carcinogenesis, and Bif1-/- mice are prone to spontaneous tumors, indicating that autophagy defects promote tumorigenesis. Due to defective mitophagy, autophagy-deficient cells accumulate damaged mitochondria and deregulated ROS levels, which likely contribute to their tumor-initiating capacity. However, the role of autophagy in tumorigenesis is complex, as more recent work also revealed tumor dependence on autophagy: autophagy-competent mutant-Ras-expressing cells form tumors more efficiently than their autophagy-deficient counterparts; similarly, FIP200 deficiency suppresses PyMT-driven mammary tumorigenesis. These latter findings are attributed to the fact that tumors driven by powerful oncogenes have high metabolic demands catered to by autophagy. In this review, we discuss the relationship between ROS and autophagy and summarize our current knowledge on their functional interactions in tumorigenesis.Keywords
This publication has 102 references indexed in Scilit:
- Oxidative stress in prostate cancerCancer Letters, 2009
- Regulation of superoxide dismutase genes: Implications in diseaseFree Radical Biology & Medicine, 2009
- Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratioFree Radical Biology & Medicine, 2009
- Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activityThe EMBO Journal, 2009
- A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cellsNature, 2008
- Essential role for Nix in autophagic maturation of erythroid cellsNature, 2008
- AMPK Phosphorylation of Raptor Mediates a Metabolic CheckpointMolecular Cell, 2008
- Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesisNature, 2007
- Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4The EMBO Journal, 2007
- Free radicals, metals and antioxidants in oxidative stress-induced cancerChemico-Biological Interactions, 2006